DarioHealth Corp
NASDAQ:DRIO
Relative Value
The Relative Value of one DRIO stock under the Base Case scenario is 6.18 USD. Compared to the current market price of 1.6 USD, DarioHealth Corp is Undervalued by 74%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
DRIO Competitors Multiples
DarioHealth Corp Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
DarioHealth Corp
NASDAQ:DRIO
|
43.5m USD | 2.1 | -0.7 | -0.6 | -0.6 | ||
US |
Abbott Laboratories
NYSE:ABT
|
183.8B USD | 4.6 | 32.6 | 19.3 | 28.7 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.9B USD | 18.6 | 68.4 | 56.1 | 70.3 | ||
US |
Stryker Corp
NYSE:SYK
|
124B USD | 5.9 | 36.9 | 24 | 29.5 | ||
IE |
Medtronic PLC
NYSE:MDT
|
108.7B USD | 3.4 | 25.9 | 13.8 | 19.5 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
106.6B USD | 7.3 | 60.4 | 30.4 | 45 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
68.3B USD | 3.5 | 56.1 | 18.8 | 39.6 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
56.2B EUR | 2.6 | 37 | 17.9 | 30.2 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
376.8B CNY | 11 | 33.2 | 29 | 29 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
51.4B USD | 13.5 | 80.3 | 60 | 78.2 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
51.2B USD | 8.3 | 36.2 | 26.3 | 28.5 |